Abstract
Neuroblastomas are characterized by defects in tumor necrosis factor-related apoptosis inducing ligand (TRAIL) induced apoptosis, especially down-regulation and methylation of Caspase-8 (CASP8). This defect is associated with amplification of N-myc. However, N-myc has also been implicated in induction of apoptosis, especially activation of CASP9 mediated apoptosis. Here we found that ectopic N-myc expression induces TRAIL susceptibility, both by CASP8 and CASP9 mediated apoptosis. N-myc did not modify CASP8 expression and methylation. CASP8 defects therefore represent an independent event in neuroblastoma, counteracting the N-myc induced susceptibility to apoptosis. Analysis of the CASP9 mediated route in a series of neuroblastoma cell lines, we found normal expression and no aberrant methylation of four apoptotic intermediates, including CASP9 itself.
Original language | English |
---|---|
Pages (from-to) | 165-72 |
Number of pages | 8 |
Journal | Cancer letters |
Volume | 197 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - 18 Jul 2003 |
Externally published | Yes |
Keywords
- Apoptosis/drug effects
- Apoptosis Regulatory Proteins
- Caspase 8
- Caspase 9
- Caspases/genetics
- DNA Methylation
- DNA Primers/chemistry
- Enzyme Inhibitors/pharmacology
- Gene Amplification
- Genes, myc/physiology
- Humans
- Membrane Glycoproteins/pharmacology
- Neuroblastoma/metabolism
- Proto-Oncogene Proteins c-myc/metabolism
- RNA, Messenger/metabolism
- Receptors, Tumor Necrosis Factor/metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- TNF-Related Apoptosis-Inducing Ligand
- Tumor Cells, Cultured
- Tumor Necrosis Factor-alpha/pharmacology
- Up-Regulation